Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Wealth
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2025 GBAF Publications Ltd - All Rights Reserved.

    ;
    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Research Reports

    The Growth Factors Market To See Growth Based On Immediate Adoption Of Advancements (Reaching US$ 1.7 Bn) Between 2021-2031

    Published by Persistence MarketResearch

    Posted on September 23, 2021

    Featured image for article about Research Reports

    The Growth Factors Market will be worth US$ 1.7 Bn at a CAGR of 7.2% between 2021-2031. With seamless digital exploration on the anvil, greater patient volume is likely to be enclosed worldwide with no geographical barriers to hold back. Telehealth is there is added to the digital transformation wave, thereby revolutionizing the healthcare vertical.

    As per Persistence Market Research’s latest revised industry analysis, the global growth factors market was valued at over US$ 1.7 Bn in 2020, and is expected to exhibit a CAGR of close to 7% over the forecast period (2021-2031).

    According to the World Health Organization (WHO), cancer caused around 9.9 million deaths worldwide in 2020. In addition, around 19.2 million people across the world were suffering from cancer. Also, increasing occurrence of autoimmune disorders is anticipated to drive demand for growth factors.

    Rising prevalence of autoimmune diseases and cancer and the benefits of cytokine and growth factors therapy in the treatment of these diseases are expected to complement market growth over the coming years.

    Growing research in the field of wound healing and skin regeneration is also expected to favor expansion of the global growth factors market. However, high cost associated with GMP grade growth factors is estimated to hamper market growth.

    Acquisitions, collaborations, and partnership agreements are rife in this landscape:

    • PPD, Inc., a leading clinical research organization, was acquired by Thermo Fisher Scientific in April 2021, expanding the company’s service offerings to pharma and biotech customers.
    • Merck and BioMed X Institute extended their collaboration to continue novel oncology and autoimmunity research in 2021.
    • In 2021, Lonza and ValenzaBio entered into a manufacturing agreement to rapidly advance VB421, an anti-IGF-1R antibody for autoimmune diseases.

    Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/4456

    Company Profiles:

    • Thermo Fisher Scientific
    • Lonza Group AG
    • Merck KGaA
    • General Electronics Company
    • F. Hoffmann-La Roche Ltd
    • Applied Biological Materials (abm), Inc.
    • Abcam plc.
    • Cell Signaling Technology, Inc.
    • Meridian Bioscience Inc.
    • Sartorius CellGenix GmbH
    • Bio-Techne.
    • Proteintech Group, Inc.
    • Miltenyi Biotec
    • Creative Bioarray
    • Akron Biotech
    • Sino Biological Inc.
    • Repligen corporation
    • LEADGENE BIOMEDICAL, INC.
    • PeproTech Inc.
    • Others

    Request for Methodology@ https://www.persistencemarketresearch.com/methodology/4456

    Key Takeaways from Market Study

    • By grade, NON-GMP grade products hold around 70% market value share, globally, primarily due to increasing focus on oncology research and growing contract research activities.
    • Based on product, interleukins are leading with over 21% market share. Strong product pipelines by various key players are positively driving demand for interleukins among growth factor products.
    • Cell therapy and ex vivo manufacturing are estimated to dominate the market by application. This segment accounted for approximately 29% share of the market, primarily due to increase in acceptance of growth factors in cancer and autoimmune therapies
    • Pharmaceutical and biotechnology companies dominate with a market share of 48%. Growing number of R&D activities and increasing preference toward growth factors for gene therapy have had a positive impact on the market.
    • North America is set to dominate the global market with a value share of around 41%. Europe is slated to be the second-largest region with a value share of 30%.

    “Rising prevalence of cancer, preference toward use of regenerative medicines, and new product launches & approvals are expected to drive market growth over the coming years,” says an analyst of Persistence Market Research.

    Demand-side Drivers:

    • Increasing focus on oncology research
    • Growing demand for growth factors and cytokines in stem cell biology
    • Increasing demand for growth factors in regenerative medicine

    Market Opportunities:

    • Shift toward fast growing Asia Pacific market
    • Limited number of companies with sole focus on GMP grade products

    Access Full Report@ https://www.persistencemarketresearch.com/checkout/4456

    Market Competition

    New product approvals, launches, collaborations, agreements, and partnerships have emerged as the main growth strategy implemented by leading players. By focusing on these strategies, key market players are strengthening their existing product portfolios to expand their geographic footprints.

    • In 2020, the humankind human cell-expressed growth factor of Proteintech Group, Inc received an ISO 13485 Certificate.
    • In 2020, Akron Biotech signed an agreement to acquire Cytiva. This acquisition helps enhance its cGMP-compliant solutions and support the development of advanced therapy.

    What Does the Report Cover?

    Persistence Market Research offers a unique perspective and actionable insights on the growth factors market in its latest study, presenting a historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

    The research study is based on the product (transforming growth factors (TGF), epidermal growth factors (EGFs), platelet-derived growth factors (PDGFs), fibroblast growth factors (FGFs), insulin-like growth factors (IGFs), vascular endothelial growth factors (VEGFs), hepatocyte growth factors (HGFs), tumour necrosis factors (TNFs), interleukins, and others), grade (GMP grade and NON-GMP grade), application (oncology research, haematology research, wound healing research, dermatology research, cardiovascular disease & diabetes, cell therapy and ex vivo manufacturing, and others), and end user (pharmaceutical and biotechnology companies, research centres & academic institutes, and CMOs & CDMOs), across seven key regions of the world.

    Related Reports:

    Ostomy Drainage Bags Market:

    These diseases are common in developed economies, particularly in the urban areas. During and after the surgery, ostomy drainage bags are used to control incontinence and discharge the wastes. Thus, the growing geriatric population is projected to drive the growth of the ostomy drainage bags market.

    Peripheral Intravenous Catheters Market:

    The global peripheral intravenous catheters market was valued at US$ 4.9 Bn in 2020, and is expected to witness a healthy CAGR of 7% during the forecast period (2020–2030).

    Dental CAD/CAM & Dental Prosthesis Market:

    In terms of revenue, the global dental CAD/CAM & dental prosthesis market is projected to register a CAGR of 5.6% over the forecast period, owing to various factors, regarding which PMR offers detailed insights and forecast.

    About Us:

    Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

    Contact Us:

    Persistence Market Research
    Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
    U.S. Ph. – +1-646-568-7751
    USA-Canada Toll-free – +1 800-961-0353
    Sales – sales@persistencemarketresearch.com
    Website – https://www.persistencemarketresearch.com

    The post The Growth Factors Market To See Growth Based On Immediate Adoption Of Advancements (Reaching US$ 1.7 Bn) Between 2021-2031 appeared first on Lake Shore Gazette.

    The Growth Factors Market will be worth US$ 1.7 Bn at a CAGR of 7.2% between 2021-2031. With seamless digital exploration on the anvil, greater patient volume is likely to be enclosed worldwide with no geographical barriers to hold back. Telehealth is there is added to the digital transformation wave, thereby revolutionizing the healthcare vertical.

    As per Persistence Market Research’s latest revised industry analysis, the global growth factors market was valued at over US$ 1.7 Bn in 2020, and is expected to exhibit a CAGR of close to 7% over the forecast period (2021-2031).

    According to the World Health Organization (WHO), cancer caused around 9.9 million deaths worldwide in 2020. In addition, around 19.2 million people across the world were suffering from cancer. Also, increasing occurrence of autoimmune disorders is anticipated to drive demand for growth factors.

    Rising prevalence of autoimmune diseases and cancer and the benefits of cytokine and growth factors therapy in the treatment of these diseases are expected to complement market growth over the coming years.

    Growing research in the field of wound healing and skin regeneration is also expected to favor expansion of the global growth factors market. However, high cost associated with GMP grade growth factors is estimated to hamper market growth.

    Acquisitions, collaborations, and partnership agreements are rife in this landscape:

    • PPD, Inc., a leading clinical research organization, was acquired by Thermo Fisher Scientific in April 2021, expanding the company’s service offerings to pharma and biotech customers.
    • Merck and BioMed X Institute extended their collaboration to continue novel oncology and autoimmunity research in 2021.
    • In 2021, Lonza and ValenzaBio entered into a manufacturing agreement to rapidly advance VB421, an anti-IGF-1R antibody for autoimmune diseases.

    Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/4456

    Company Profiles:

    • Thermo Fisher Scientific
    • Lonza Group AG
    • Merck KGaA
    • General Electronics Company
    • F. Hoffmann-La Roche Ltd
    • Applied Biological Materials (abm), Inc.
    • Abcam plc.
    • Cell Signaling Technology, Inc.
    • Meridian Bioscience Inc.
    • Sartorius CellGenix GmbH
    • Bio-Techne.
    • Proteintech Group, Inc.
    • Miltenyi Biotec
    • Creative Bioarray
    • Akron Biotech
    • Sino Biological Inc.
    • Repligen corporation
    • LEADGENE BIOMEDICAL, INC.
    • PeproTech Inc.
    • Others

    Request for Methodology@ https://www.persistencemarketresearch.com/methodology/4456

    Key Takeaways from Market Study

    • By grade, NON-GMP grade products hold around 70% market value share, globally, primarily due to increasing focus on oncology research and growing contract research activities.
    • Based on product, interleukins are leading with over 21% market share. Strong product pipelines by various key players are positively driving demand for interleukins among growth factor products.
    • Cell therapy and ex vivo manufacturing are estimated to dominate the market by application. This segment accounted for approximately 29% share of the market, primarily due to increase in acceptance of growth factors in cancer and autoimmune therapies
    • Pharmaceutical and biotechnology companies dominate with a market share of 48%. Growing number of R&D activities and increasing preference toward growth factors for gene therapy have had a positive impact on the market.
    • North America is set to dominate the global market with a value share of around 41%. Europe is slated to be the second-largest region with a value share of 30%.

    “Rising prevalence of cancer, preference toward use of regenerative medicines, and new product launches & approvals are expected to drive market growth over the coming years,” says an analyst of Persistence Market Research.

    Demand-side Drivers:

    • Increasing focus on oncology research
    • Growing demand for growth factors and cytokines in stem cell biology
    • Increasing demand for growth factors in regenerative medicine

    Market Opportunities:

    • Shift toward fast growing Asia Pacific market
    • Limited number of companies with sole focus on GMP grade products

    Access Full Report@ https://www.persistencemarketresearch.com/checkout/4456

    Market Competition

    New product approvals, launches, collaborations, agreements, and partnerships have emerged as the main growth strategy implemented by leading players. By focusing on these strategies, key market players are strengthening their existing product portfolios to expand their geographic footprints.

    • In 2020, the humankind human cell-expressed growth factor of Proteintech Group, Inc received an ISO 13485 Certificate.
    • In 2020, Akron Biotech signed an agreement to acquire Cytiva. This acquisition helps enhance its cGMP-compliant solutions and support the development of advanced therapy.

    What Does the Report Cover?

    Persistence Market Research offers a unique perspective and actionable insights on the growth factors market in its latest study, presenting a historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

    The research study is based on the product (transforming growth factors (TGF), epidermal growth factors (EGFs), platelet-derived growth factors (PDGFs), fibroblast growth factors (FGFs), insulin-like growth factors (IGFs), vascular endothelial growth factors (VEGFs), hepatocyte growth factors (HGFs), tumour necrosis factors (TNFs), interleukins, and others), grade (GMP grade and NON-GMP grade), application (oncology research, haematology research, wound healing research, dermatology research, cardiovascular disease & diabetes, cell therapy and ex vivo manufacturing, and others), and end user (pharmaceutical and biotechnology companies, research centres & academic institutes, and CMOs & CDMOs), across seven key regions of the world.

    Related Reports:

    Ostomy Drainage Bags Market:

    These diseases are common in developed economies, particularly in the urban areas. During and after the surgery, ostomy drainage bags are used to control incontinence and discharge the wastes. Thus, the growing geriatric population is projected to drive the growth of the ostomy drainage bags market.

    Peripheral Intravenous Catheters Market:

    The global peripheral intravenous catheters market was valued at US$ 4.9 Bn in 2020, and is expected to witness a healthy CAGR of 7% during the forecast period (2020–2030).

    Dental CAD/CAM & Dental Prosthesis Market:

    In terms of revenue, the global dental CAD/CAM & dental prosthesis market is projected to register a CAGR of 5.6% over the forecast period, owing to various factors, regarding which PMR offers detailed insights and forecast.

    About Us:

    Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

    Contact Us:

    Persistence Market Research
    Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
    U.S. Ph. – +1-646-568-7751
    USA-Canada Toll-free – +1 800-961-0353
    Sales – sales@persistencemarketresearch.com
    Website – https://www.persistencemarketresearch.com

    The post The Growth Factors Market To See Growth Based On Immediate Adoption Of Advancements (Reaching US$ 1.7 Bn) Between 2021-2031 appeared first on Lake Shore Gazette.

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe